This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Questions Answered in this Report:
- What are the major market drivers, restraining factors, and opportunities in the global RNA sequencing market?
- What are the underlying structures resulting in the emerging trends within the global RNA sequencing market?
- What are the key development strategies which are incorporated by the major players in order to sustain in the competitive market?
- What are the key regulatory implications in developed and developing regions for RNA sequencing?
- What are the key patents obtained by the companies for various technologies in the global RNA sequencing market?
- How each segment of the market is anticipated to grow during the forecast period 2019 to 2028 and what is the estimated revenue to be generated by each of the segments on the basis of:
- product type, including types of instruments, reagents, and kits, and software
- technology, including, single-molecule-based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent sequencing technology
- workflow, including sample enrichment, nucleic acid isolation and extraction, library preparation, sequencing, and data analysis and management
- end-user, including biopharmaceuticals, life science and biotechnology companies, diagnostic centers, and research and academia
- applications, including drug discovery, translational medicine, diagnostics, and others
- region, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World
- Who are the leading players with significant offerings to the global RNA sequencing market? What is the anticipated market dominance for each of these leading players?
- Which companies are anticipated to be highly disruptive in the future and why?
- What are the challenges in the global RNA sequencing market currently?
The RNA sequencing industry analysis projects the market to grow at a significant CAGR of 14.21% during the forecast period, 2019-2028. The RNA sequencing market generated $1,064.6 million in revenue in 2019, in terms of value. The RNA sequencing market growth has been primarily attributed to the major drivers in this market, such as an increase in adoption of personalized medicine, increased utility in patient stratification and therapeutic response research, and significant external funding for executing research and development. However, the expected implementation of patient protection and affordable care act in the U.S., existing lawsuits, and lack of approval with uncertain reimbursement and regulatory policies, among others, are restraining market growth.
Expert Quote
“We are proud to continue our tradition of driving down the cost of sequencing without compromising accuracy. Products are designed to enable core labs, small to medium research labs, and clinical facilities to access high-intensity sequencing applications using our industry-leading SBS technology.”
Scope of the Market Intelligence on RNA sequencing Market
The RNA sequencing research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers. In addition, the study also includes exhaustive information on the challenges, opportunities, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global RNA sequencing market.
Market Segmentation
- The RNA sequencing market (on the basis of the manufacturer) is segmented into product, technology, workflow, end-user, application, and region.
- The RNA sequencing market (on the basis of product) is segmented into instruments, reagents and kits, and software.
- The RNA sequencing market (on the basis of technology) is segmented into single molecule-based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent semiconductor sequencing.
- The RNA sequencing market (on the basis of workflow) is segmented into sample enrichment, nucleic acid isolation and extraction, library preparation, sequencing, and data analysis and management.
- The RNA sequencing market (on the basis of end-user) is segmented into biopharmaceuticals, life-sciences and biotechnology companies, diagnostic centers, and research and academia.
- The RNA sequencing market (on the basis of application) is segmented into drug discovery, translational medicine, diagnostics, and others.
Key Companies in the RNA Sequencing Market
The key manufacturers who have been contributing significantly to the RNA sequencing market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI, F. Hoffmann La-Roche AG, Fluidigm Corporation, Illumina, Inc., Lexogen GmbH, Oxford Nanopore Technologies, Pacific Biosciences, QIAGEN N.V., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Dolomite Bio, Takara Bio Inc., and Merck KGaA., among others.
Table of Contents
Executive Summary
Samples
LOADING...
Executive Summary
According to the market intelligence report titled “Global RNA Sequencing Market- Analysis and Forecast, 2019-2028”, the global RNA sequencing market was valued at $976.1 million in 2018 and is anticipated to grow over $3,521.0 million by 2028. The global RNA sequencing market is expected to grow at double-digit compound annual growth rate in the forecast period 2019-2028, aided primarily by the impressive growth in the manufacturing market.
RNA sequencing has emerged as one of the most promising techniques in the field of genomics. It is a recent technique that emerged after the invention of next-generation sequencing. Earlier, Sanger sequencing techniques and microarray-based methods were used for genome analysis. Compared with the earlier methods, RNA sequencing offers a combination of higher coverage and greater resolution for the analysis of the transcriptome. Current advancements in the RNA sequencing workflow, including sample preparation, sequencing instruments, and data analysis software, among others, has significantly provided unprecedented opportunities for executing transcriptome profiling.
According to Nitish Singh, Analyst, “North America is the leading contributor in the RNA sequencing market and contributed approximately 41.65% to the global market value in 2018. This region is anticipated to grow at a CAGR of 14.16% during the forecast period 2019-2028 and continue dominating the global market in 2028 as well. However, the Asia-Pacific region is expected to grow at an impressive CAGR of 14.59% during the forecast period from 2019-2028. The European region also contributed a significant share of 28.40% to the global market and is anticipated to grow at a CAGR of 14.25% during the forecast period from 2019-2028.”
Research Highlights:
Sequence by synthesis technology is expected to witness a robust CAGR of 14.31% during the forecast period 2019-2028. However, the RNA sequencing market for reagents and kits is anticipated to witness the growth of 14.49% during the forecast period 2019-2028.
Illumina, Inc., is currently the largest shareholder in the global RNA sequencing market. This market dominance is attributed to the company’s presence within the market through its dedicated product mix for RNA sequencing.
This market intelligence report provides a multi-dimensional view of the global RNA sequencing market in terms of market size and growth potential. This research report aims at answering various aspects of the global RNA sequencing market with the help of key factors driving the market, restraints that can possibly inhibit the overall growth of the market, and the current growth opportunities that are going to shape the future trajectory of the market expansion.
Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches and upgradations, approvals, partnerships, collaborations, business expansions, as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of product sales, manufacturers, and trend analysis by segment, market share, and growth-share analysis by companies. Additionally, the report provides a comprehensive, attractive analysis and opportunity analysis for the entire RNA sequencing market for 2018 and 2028.
This report is a meticulous compilation of research on more than 25 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 20 leading and emerging companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI, F. Hoffmann La-Roche AG, Fluidigm Corporation, Illumina, Inc., Lexogen GmbH, Oxford Nanopore Technologies, Pacific Biosciences, QIAGEN N.V., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Dolomite Bio, Takara Bio Inc., and Merck KGaA.
The answers to the following key questions can be derived from this report:
- What are the major market drivers, restraining factors, and opportunities in the global RNA sequencing market?
- What are the underlying structures resulting in the emerging trends within the global RNA sequencing market?
- What are the key development strategies which are incorporated by the major players in order to sustain in the competitive market?
- What are the key regulatory implications in developed and developing regions for RNA sequencing?
- What are the key patents obtained by the companies for various technologies in the global RNA sequencing market?
- How each segment of the market is anticipated to grow during the forecast period 2019 to 2028 and what is the estimated revenue to be generated by each of the segments on the basis of:
- product type, including types of instruments, reagents, and kits, and software
- technology, including, single-molecule-based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent sequencing technology
- workflow, including sample enrichment, nucleic acid isolation and extraction, library preparation, sequencing, and data analysis and management
- end user, including biopharmaceuticals, life science and biotechnology companies, diagnostic centers, and research and academia
- applications, including drug discovery, translational medicine, diagnostics, and others
- region, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World
- Who are the leading players with significant offering to the global RNA sequencing market? What is the anticipated market dominance for each of these leading players?
- Which companies are anticipated to be highly disruptive in the future and why?
- What are the challenges in the global RNA sequencing market currently?
Key trends targeted in the report:
- What are the emerging trends in the global RNA sequencing market?
- Which companies are anticipated to be highly disruptive in the future and why?
Companies Mentioned
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- BGI
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- Illumina, Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
- Pacific Biosciences
- Dolomite Bio
- Merck KGaA
- Becton, Dickinson, and Company
- Takara Bio Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.